Table 3 Results of competing risks model compared to the Cox PH model
From: Venous thromboembolism in patients with acute myeloid leukemia: development of a predictive model
Analyzed variable | Competing Risks | Cox | ||
|---|---|---|---|---|
sHR (95% CI) | p-value | HR (95% CI) | p-value | |
Sex (male vs. female) | 1.92 (1.14–3.23) | 0.014 | 1.84 (1.08–3.14) | 0.024 |
Previous thrombosis | 2.39 (1.20–4.77) | 0.013 | 2.25 (1.11–4.56) | 0.025 |
ECOG PS | 0.75 (0.56–1.01) | 0.056 | 0.83 (0.62–1.11) | 0.203 |
iNR | 0.28 (0.05–1.68) | 0.160 | 0.38 (0.08–1.89) | 0.239 |
Therapy type (intensive vs. non-intensive) | 1.33 (0.70–2.55) | 0.390 | 1.16 (0.61–2.22) | 0.652 |